Form 4: Enovis Director Liam Kelly Acquires 9,346 Shares

Director Liam Kelly acquired 9,346 shares of Enovis Corp common stock on May 19, 2026.

Summary

• Director Liam Kelly increased his stake in Enovis Corp (ENOV) through an acquisition of 9,346 shares.
• The transaction occurred on May 19, 2026.
• The shares were acquired at a price of $0.00, indicating an equity grant or compensation-related issuance.
• Following this transaction, the director's total beneficial ownership stands at 28,950 shares.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral-to-positive event, as it reflects standard director compensation and increased insider skin-in-the-game.

Positives

• Director alignment with shareholder interests increased through the acquisition of additional equity.

Negatives

• None identified in this filing.

Risks

• None identified in this filing.

Future Outlook

Not applicable as this is a standard insider transaction filing.

Industry Context

StockSavvy.ai notes that director equity acquisitions are generally viewed as a positive signal of management confidence in the company's long-term strategic direction within the medical technology sector.

Comparison to Industry Standards

• The acquisition aligns with standard corporate governance practices where directors receive equity-based compensation to ensure long-term alignment with shareholders.

Stakeholder Impact

• Shareholders may view the increased director ownership as a sign of confidence in the company's future performance.

Key Dates

Keywords

Enovis, ENOV, Insider Trading, Form 4, Director Ownership, Equity Compensation